Search by Drug Name or NDC

    NDC 50382-0052-13 Galentic Triple Antibiotic Plus Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g Details

    Galentic Triple Antibiotic Plus Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g

    Galentic Triple Antibiotic Plus Pain Relief is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Galentic Pharma (India) Private Limited. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE.

    Product Information

    NDC 50382-0052
    Product ID 50382-052_98b72992-858d-22f6-e053-2a95a90a950f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Galentic Triple Antibiotic Plus Pain Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form OINTMENT
    Route TOPICAL
    Active Ingredient Strength 500; 3.5; 10000; 10
    Active Ingredient Units [USP'U]/g; mg/g; [USP'U]/g; mg/g
    Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
    Labeler Name Galentic Pharma (India) Private Limited
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part333B
    Listing Certified Through 2023-12-31

    Package

    NDC 50382-0052-13 (50382005213)

    NDC Package Code 50382-052-13
    Billing NDC 50382005213
    Package 28 g in 1 TUBE (50382-052-13)
    Marketing Start Date 2019-12-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 08e923b4-e3c1-4a20-a112-1b5176bfb285 Details

    Revised: 10/2020